Advertisement

Topics

Cima Group Company Profile

15:44 EDT 20th June 2019 | BioPortfolio

Cima Group is a global telecommunications and digital solutions provider and integrator. Since 1981, Cima Group has provided retail and wholesale voice services, and value-added platform services such as Analytics, Automation and Engagement. Cima Group is committed to delivering simple solutions through reliable technology and innovative services.


News Articles [658 Associated News Articles listed on BioPortfolio]

Global Ophthalmic Viscosurgical Devices OVD Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Ophthalmic Viscosurgical Devices OVD market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastReg...

IFG Group plc: Holding(s) in Company - Goldman Sachs Group

Dow Jones received a payment from EQS/DGAP to publish this press release. IFG Group plc (IFP) IFG Group plc: Holding(s) in Company - Goldman Sachs Group 03-May-2019 / 08:48 GMT/BST Dissemination o...

Zur Rose Group announces result of rights take-up

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 28.11.2018 / 17:35 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 29.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Maricann Group Inc.: Mit Volldampf in die Zukunft! - CEO Ben Ward gibt Ausblick über hervorragende Entwicklung der Wayland Group

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-11-21 / 10:42 *Unternehmen: Wayland Group (ehemals Maricann Group.....

#Cannabisstocks: Cronos Group (NASDAQ: $CRON) (TSX: $CRON.TO) Confirms Discussions Regarding Potential Investment by Altria Group (NYSE: $MO)

TORONTO - December 4, 2018 (Investorideas.com Newswire) Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") confirmed that it is engaged in discussions concerning a potentia...

Maricann Group Inc.: Sensations Coup! Einstieg in argentinischen Cannabis Markt - Wayland Group erwirbt über 800 Hektar Anbaufläche!

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-12-11 / 07:20 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Capital increase of the Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 04.12.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Modafinil [cima labs inc.]

These highlights do not include all the information needed to use modafinil safely and effectively. See full prescribing information for modafinil. Modafinil tablets, for oral use, C-IV Initial U.S. A...

Kemstro™ (baclofen orally disintegrating tablets) [schwarz pharma]

KEMSTRO™ (baclofen orally disintegrating tablets)

PubMed Articles [1653 Associated PubMed Articles listed on BioPortfolio]

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan.

The 2017 GOLD ABCD classification shifts patients from groups C-D to A-B. Group A was the most widely distributed group in several studies. It would be useful to understand the characteristics for gro...

Appearance of large scavenger receptor A-positive cells in peripheral blood: A potential risk factor for severe exacerbation of chronic obstructive pulmonary disease.

Fresh peripheral blood (PB) samples from 432 outpatients with stable chronic obstructive pulmonary disease (COPD) were examined. Patients were classified into Group A (large SRA cells were undetected)...

The apoptotic effects of bisphenol A exposure on the rat ovary: an experimental study.

Bisphenol A (BPA) is a key endocrine-disrupting chemical (EDC) in the manufacturing industry. It is found in the structure of compounds such as polycarbonate and epoxy in combination with other chemic...

Lamina cribrosa morphology in glaucomatous eyes with hemifield defect in a Korean population.

To compare regional variations in lamina cribrosa (LC) curvature and depth between healthy eyes (Group 1) and naïve eyes with primary open-angle glaucoma (POAG) having superior (Group 2), inferior (G...

New stoichiometric compounds of Au-Hg system under high pressure.

We have extensively explored Au-Hg system under high pressure in the range of 0-300 GPa with and without spin-orbit coupling (SOC) inclusion. The variable-composition methodology has been used as empl...

Clinical Trials [4578 Associated Clinical Trials listed on BioPortfolio]

National Bank Alzheimer

The Alzheimer's disease (MY) is a major problem of public health. The French National Database Alzheimer ( BNA) registers(records) all the medical acts made by units of memory(report) and ...

Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma

Multicentric and prospective epidemiological study (NON INTERVETIONAL) to identify prognosis and predictive biomarkers of response to sunitinib and pazopanib as first line therapy in metst...

A Comparison of Primary Care and Traditional Internal Medicine Residents

The goal of this study is to identify objective differences between primary care and traditional medicine residents in clinical performance, continuity of care and utilization of resources...

Combined, Intensified and Modulated Adjuvant Therapy in Prostate Carcinoma

Patients with high risk prostate cancer may benefit from radiotherapy after radical prostatectomy. The investigators postulated that adjuvant androgen deprivation therapy (ADT), radiation ...

MAC-cbt Group Therapy for Adults With ADHD

The study is developed to validate a new short psychotherapeutic group treatment for adults with ADHD diagnosis. The participants will be treated in a monocentric, parallel group randomize...

Companies [1680 Associated Companies listed on BioPortfolio]

Cima Group

Cima Group is a global telecommunications and digital solutions provider and integrator. Since 1981, Cima Group has provided retail and wholesale voice services, and value-...

Cima Laboratories Incorporated

CIMA LABS INC. develops and manufactures prescription and over-the-counter products based upon its proprietary, fast-dissolve drug delivery technologies, OraSolv® and DuraSolv®. Based on our techn...

CIMA LABS INC

CIMA LABS INC. is a drug delivery technology company. We develop and manufacture prescription and over-the-counter medication based on proprietary, orally disintegrating technologies (also referred to...

Cima NanoTech

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

More Information about "Cima Group" on BioPortfolio

We have published hundreds of Cima Group news stories on BioPortfolio along with dozens of Cima Group Clinical Trials and PubMed Articles about Cima Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cima Group Companies in our database. You can also find out about relevant Cima Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record